Clinical Adventurer

In this episode, we explore the case of a 71-year-old male brought to the emergency department after spending two days bedridden, unable to care for himself, and without food intake. Presenting with generalized weakness, dizziness, headache, and vomiting, the patient’s condition is complicated by a history of coronary artery disease, hypertension, congestive heart failure, and type 2 diabetes.Initial evaluation reveals atrial flutter, leukocytosis, and acute kidney injury, raising concerns about multiple underlying and potentially interconnected disease processes.Follow the clinical team as they interpret diagnostic findings, prioritize interventions, and navigate the challenges of managing a medically complex patient. This case highlights the importance of recognizing clinical deterioration, understanding the relationships between cardiovascular and renal dysfunction, and applying clinical judgment to guide safe, effective patient care.

In this episode, we explore the case of a 71-year-old male brought to the emergency department after spending two days bedridden, unable to care for himself, and without food intake. Presenting with generalized weakness, dizziness, headache, and vomiting, the patient’s condition is complicated by a history of coronary artery disease, hypertension, congestive heart failure, and type 2 diabetes.Initial evaluation reveals atrial flutter, leukocytosis, and acute kidney injury, raising concerns about multiple underlying and potentially interconnected disease processes.Follow the clinical team as they interpret diagnostic findings, prioritize interventions, and navigate the challenges of managing a medically complex patient. This case highlights the importance of recognizing clinical deterioration, understanding the relationships between cardiovascular and renal dysfunction, and applying clinical judgment to guide safe, effective patient care.

The episode is an in-depth clinical case review centered on 67-year-old Roberto Aguilar, who presents with presumed acute myeloid leukemia (AML). It unpacks how leukemic blasts crowd the bone marrow space, creating a stark paradox where a total white blood cell count of 42,300/µL masks anAbsolute Neutrophil Count of only 420/µL and leaves the patient severely immunocompromised. The episode examines the mechanics of tri-lineage marrow failure. It explains why normal coagulation times co-exist with active bleeding when platelets drop to 18,000/µL. It also audits critical chart errors such as administering subcutaneous enoxaparin and continuing aspirin despite severe thrombocytopenia. Finally, it highlights the danger of misattributing febrile neutropenia to leukemic B-symptoms and outlines immediate nursing priorities for managing sepsis, tumor lysis syndrome, and urgent care escalation.This accompanies the hematology case studies in UH Maui College’s N212 course.

This podcast episode breaks down a case focusing on a 44-year-old patient who presents with progressive fatigue, exertional dyspnea, and tachycardia. It explores the critical clinical paradox between oxygen saturation and oxygen-carrying capacity, detailing how a patient can maintain a pulse oximetry reading of 99% SpO₂ while experiencing severe tissue hypoxia due to microcytic iron deficiency anemia. The host discussion walks through the underlying mechanisms of chronic blood loss from heavy menses and occult gastrointestinal bleeding compounded by daily aspirin use and audits how serial chart misinterpretations, such as misdiagnosing her condition as anemia of chronic disease and continuing antiplatelet therapy, were repeatedly passed along during nursing handoffs.This accompanies the hematology case studies in UH Maui College’s N212 course.

A bowel obstruction, a suspected malignancy, and multiple comorbidities — this case had all the makings of a clinical storm. In this episode of Clinical Adventurer, we walk through the complex hospital course of a 72-year-old male whose sigmoid stricture led to large bowel obstruction, feculent peritonitis, and septic shock. From emergent surgeries and ICU-level vasopressor support to managing cardiac instability and thrombocytopenia, we unpack the critical decision points, pathophysiology, and bedside nursing priorities that shaped his care. All patient identifiers have been changed. If you’re ready for a deep dive into surgical complications, sepsis physiology, and real-world nursing strategy, this is one you won’t want to miss.

The coagulation cascade isn’t just a lecture topic—it’s a life-or-death system unfolding in real time in trauma bays, ORs, and ICUs. What happens when the cascade misfires? In this episode, we explore not just the science, but the stories, of three patients whose bleeding or clotting disorders reveal the power and peril of the clotting cascade. From a child with hemarthrosis to a septic patient in DIC, you’ll see how lab values like INR and aPTT are more than just numbers—they're clinical lifelines.

Ever wonder what PT, INR, or aPTT actually mean—and why they matter right now at the bedside? In this episode, we’re cracking open the coagulation cascade to uncover how common clotting labs can reveal life-threatening risks like bleeding, clot formation, liver dysfunction, or anticoagulant overdose. Whether you’re titrating heparin, checking warfarin levels, or ruling out a PE, you need more than just a normal range—you need context.

When seconds count, your patient’s lab results can be the difference between catching a heart attack early or missing a silent killer. In this episode, we break down cardiac biomarkers — what they really mean, how to interpret them, and why troponins reign supreme in today’s high-stakes cardiac care. We’ll walk you through the science, the pitfalls, and the nursing implications so you can make sense of those critical labs in real time.🧠 Key Topics Covered:What Are Cardiac Biomarkers?Substances released during cardiac muscle injuryTheir role in diagnosing Acute Myocardial Infarction (AMI) and Acute Coronary Syndromes (ACS)Troponin I and T – The Gold Standard:Why they replaced AST, LDH, and CK-MBSensitivity, specificity, and timing of elevationClinical relevance of high-sensitivity troponin assaysOther Biomarkers in Context:CK-MB and myoglobin: When they’re still usedBNP and NT-proBNP: For heart failure assessment (vs ischemia)Timing and Trends Matter:Serial troponin testing and rise/fall patternsHow early peaks and delayed elevations affect diagnosisFalse Positives and Interfering Factors:Sepsis, renal failure, pulmonary embolism, and chronic diseasePre-analytical issues: Hemolysis, improper timing, and specimen handlingDiagnostic Criteria for AMI (Fourth Universal Definition):Troponin changes + clinical signs + ECG changesType 1 vs Type 2 MI differentiationNursing and Interprofessional Implications:When to alert the providerHow to prepare patients for serial testingCollaborating with lab, cardiology, and emergency teams for timely action

Not all kidneys fail loudly. Sometimes the earliest signs are hidden in the labs — if you know where to look. In this episode, we go deep into renal function testing, breaking down how to spot trouble early, stage chronic kidney disease accurately, and make sense of the numbers that don’t always tell the full story. Whether you're monitoring a dialysis patient or picking up subtle trends in a post-op patient, this episode equips you with the clinical insight to interpret renal labs with confidence.Key Topics Covered:GFR (Glomerular Filtration Rate):Why it’s the gold standardEstimated vs measured GFRCreatinine vs cystatin CLimitations and influencing factors (age, muscle mass, etc.)KDIGO CKD Staging:GFR and albuminuria categoriesClinical relevance in guiding treatmentCreatinine and BUN:What they measure and what they missBUN/Cr ratio and what it tells you about prerenal vs intrinsic causesAlbuminuria/Proteinuria:Spot urine vs 24-hour collectionWhy microalbuminuria mattersUrinalysis (UA):Key elements: Specific gravity, pH, protein, casts, sedimentClues for glomerular vs tubular vs post-renal pathologyTubular Function Tests:Fractional excretion of sodium (FeNa), urine osmolality, and concentrating abilityClinical Pearls:How hydration, medications, and diet can skew resultsWhen to question the numbers and what to do nextNursing implications for trending renal labs, fluid management, and alerting providers

Think a high AST or ALT means your patient’s liver is failing? Think again. Liver function tests are one of the most misunderstood panels in clinical practice — often called "function" tests, yet many don’t measure function at all.In this episode, we break down the real meaning behind LFTs, explore the different patterns of liver injury, and help you interpret these labs like a pro. Whether it’s differentiating between cholestasis and hepatocellular injury, or figuring out when to worry about that isolated bilirubin bump, we’ve got you covered with pathophysiology, clinical reasoning, and nursing implications.🧠 Key Topics Covered:Why “LFT” is often a misnomerTrue measures of liver function: Albumin, PT/INRInjury patterns:Hepatocellular (↑ AST/ALT)Cholestatic (↑ ALP/GGT)Mixed patternsIsolated hyperbilirubinemiaWhat each test actually tells you:ALT/AST – hepatocellular enzymesALP/GGT – biliary obstruction cluesBilirubin – excretory function vs hemolysisAlbumin, PT/INR – synthetic function markersCommon causes of abnormal labs:Medications, alcohol, viral hepatitis, fatty liver, hemolysis, specimen errorHow to link lab patterns to clinical conditionsWhen to escalate care or consult hepatology